Skip to content

Alaris, SmartSite 24001-0007Recalls & reported problems

BD Switzerland Sàrl · Pump Infusion Set, Back Check Valve Y-Site 120 cm (47 in) · Class 2

All models of Alaris, SmartSite (160)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
2

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10885403238666), received between Sep 22, 2020 and Oct 15, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Complete Blockage” (1 report).

2 FDA recall records name this device's identifier, 2 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 8, 2025Class IOpen, Classified

    Infusion pump module used with compatible pump infusion sets may perform outside the established performance ranges for flow rate and bolus accuracy, downstream and upstream occlusion time to alarm, and post-occlusion bolos volume.

    Z-2180-2025 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  2. Oct 11, 2023Class IIOpen, Classified

    Affected infusion sets labeled as free of DEHP actually do contain di(2-ethylhexyl) phthalate (DEHP).

    Z-0349-2024 · Root cause: Error in labeling · Recall details · FDA record ↗

Most reported problems

Device problems

  • Complete Blockage1
  • Leak/Splash1
  • Restricted Flow rate1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 15, 2025Leak/Splash; Leak/Splash

    EVENT DETAILS: THE TUBING IS LEAKING AROUND THE LITTLE BLUE CLAP. GETTING AN ERROR MESSAGE THAT THERE IS AIR IN THE TUBING.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23302103 ↗
  • MalfunctionSep 22, 2020Complete Blockage; Restricted Flow rate; Complete Blockage; Restricted Flow rate

    IT WAS REPORTED THAT AS LVP 20D SS CV WAS OCCLUDED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: UNKNOWN FILTER BATCH NO: UNKNOWN. IT WAS REPORTED WOULD NOT INFUSE WHILE USING PUMP WITH FILTER. CAN YOU PLEASE PROVIDE IN DETAILS AS TO WHAT REALLY HAPPENED WHEN THE PUMP ALARMED. WHAT MESSAGE DID THE ALARM SHOW (ERROR CODE/MESSAGE)? DID THE PUMP SHUT OFF (BATTERY ISSUE)? ACCORDING TO OUR CLINICAL SITE, ¿OCCLUDED¿ WAS THE ALARM READOUT. THE FOLLOWING IS THE SUMMARY OF WHAT HAPPENED WITH THE PUMP: ¿ON (B)(6) 2020 A IOMAB-B THERAPEUTIC INFUSION WAS PERFORMED FOR PATIENT WITH A FILTER IN THE INFUSION LINE. THE ALARIS PUMP ALARMED SHORTLY AFTER STARTING THE INFUSION, WHICH IS COMMON BASED ON CLAMPING THE LINES, AND THE TEAM WAS ABLE TO ADDRESS THE ALARM AND PROCEED WITH THE INFUSION. WITHIN APPROXIMATELY 30 MINUTES THE PUMP ALARMED AGAIN, AND ALARMS CONTINUED TO OCCUR DESPITE THE TEAM TRYING TO RESOLVE THE SOURCE OF THE ISSUE. THE CLINICAL SITE STAFF EVALUATED THE ISSUE AND SUSPECTED THE ADDITIONAL FILTER TO BE THE SOURCE OF THE PROBLEM. THE INFUSION WAS PAUSED, A SECOND FILTER WAS CAREFULLY BACK-PRIMED AND THE ORIGINAL FILTER AND THE INFUSION RESTARTED. THE

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10570925 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page